Safety and Efficacy of Elobixibat, an Ileal Bile Acid Transporter Inhibitor, in Elderly Patients With Chronic Idiopathic Constipation According to Administration Time: Interim Analysis of Post-marketing Surveillance

BACKGROUND/AIMS: Elobixibat, an ileal bile acid transporter (apical sodium-dependent bile acid transporter) inhibitor, was recently launched in Japan for the treatment of chronic idiopathic constipation. We conducted an interim analysis of post-marketing surveillance to evaluate the safety and effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Atsushi, Fujimaki, Mio, Arai, Yuki, Emori, Kento
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Neurogastroenterology and Motility 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274463/
https://www.ncbi.nlm.nih.gov/pubmed/35799237
http://dx.doi.org/10.5056/jnm20263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274463/
https://www.ncbi.nlm.nih.gov/pubmed/35799237
http://dx.doi.org/10.5056/jnm20263

Ejemplares similares